Welcome Back

Google icon Sign in with Google
OR
I agree to abide by Pharmadaily Terms of Service and its Privacy Policy

Create Account

Google icon Sign up with Google
OR
By signing up, you agree to our Terms of Service and Privacy Policy
Instagram
youtube
Facebook

Niramai

About Company

Niramai is an Indian healthcare technology company focused on early breast cancer detection using a non-invasive, radiation-free AI-based screening method called "Thermalytix," which analyzes thermal images to identify potential abnormalities in the breast, allowing for earlier detection than traditional methods; the company's core technology utilizes machine learning algorithms to analyze these thermal images, making it a privacy-conscious and accessible option for women of all ages. 

Key points about Niramai:

  • Technology:

    Their flagship product, Thermalytix, is a portable, automated device that uses thermal imaging and AI to detect breast cancer without the need for radiation or physical contact. 

  • Benefits:

    Niramai's technology is considered to be a more accessible and comfortable alternative to traditional breast cancer screening methods like mammograms, particularly for women with dense breasts. 

  • Impact:

    Niramai aims to improve early detection rates for breast cancer, especially in areas with limited access to healthcare facilities. 

  • Company details:

    • Founders: Dr. Geetha Manjunath and Nidhi Mathur 
    • Location: India 
    • Funding: Received investments from various venture capitalists including Dream Incubator, BeeNext, and Axilor Ventures 
    • Awards and recognition: Niramai has won several awards including the World Bank's Global Women HealthTech Award 

Pharma Jobs in Niramai